Affordable Access

Preparation of tissue-specific monoclonal antibodies using purified endothelial membrane proteins from biotinylated pulmonary vasculature of rhesus monkey.

Authors
  • Zhang, Wei
  • Zhou, Ying-Jiang
  • Guo, Zhi-Gang
  • Bi, Feng
  • Zhang, Jing
  • Kumar, Pat
  • Tan, Xiang-Yang
  • Liu, Jian-Ning
Type
Published Article
Journal
Hybridoma (2005)
Publication Date
Feb 01, 2006
Volume
25
Issue
1
Pages
15–19
Identifiers
PMID: 16475877
Source
Medline
License
Unknown

Abstract

In the present study, we perfused the rhesus lung vascular bed in situ with sulfo-NHS-LC-Biotin to biotinylate its luminal surface membrane proteins. After homogenization, dialysis, and affinity chromatography, biotinylated endothelial membrane proteins were successfully isolated and characterized as enriched endothelial membrane proteins with no contamination of intracellular proteins. When they were used as immunogens to develop monoclonal antibodies (MAbs), three MAbs--TX111, TX112, and TX113--were obtained. Among them, TX111 was demonstrated to specifically bind to rhesus lung tissue by Western blotting and enzymelinked immunosorbent assay (ELISA)--that is, positively stained capillary endothelium of rhesus lung. The molecular weight of the corresponding antigen for TX111 was approximately 70 kDa under reducing conditions. TX111 also reacted with human lung homogenate, but not with rat lung homogenate. These results suggest that (1) the biotinylation method is applicable for isolating endothelial proteins in situ from large animals; (2) anti-human protein MAbs are likely to be obtained using monkey proteins; and (3) TX111 is potentially useful for pulmonary vascular targeting.

Report this publication

Statistics

Seen <100 times